DE-117 Spectrum 5 Study

Clinical trial NCT03697811 · COMPLETED

Trial details

NCT number: NCT03697811
Sponsor: Santen Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Open-angle Glaucoma and Ocular Hypertension

Start date: 2018-09-27
Primary completion: 2022-01-13
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.